BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 6, Pages 947-955
Publisher
Springer Nature
Online
2012-08-15
DOI
10.1038/bjc.2012.351
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
- (2010) M F E Godinho et al. BRITISH JOURNAL OF CANCER
- Does Lapatinib Work against HER2-negative Breast Cancers?
- (2010) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer with Acquired Endocrine Resistance
- (2010) A. F. Leary et al. CLINICAL CANCER RESEARCH
- Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling
- (2010) I. Barone et al. CLINICAL CANCER RESEARCH
- Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells
- (2010) Marcia Godinho et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
- (2009) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response
- (2009) Ton van Agthoven et al. ENDOCRINE-RELATED CANCER
- Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
- (2009) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts
- (2008) C. J. Creighton et al. CANCER RESEARCH
- Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance
- (2008) Ton van Agthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity
- (2008) M Scaltriti et al. ONCOGENE
- Identification of Nucleolin as New ErbB Receptors- Interacting Protein
- (2008) Ayelet Di Segni et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search